Agonist and antagonist recognition studies for oestrogen receptor by molecular dynamics simulation

被引:9
|
作者
Li, Wen-Ming [1 ]
Li, Xiao-Bo [1 ]
Sun, Su-Xia [1 ]
Liang, Jing [1 ]
Wang, Run-Ling [1 ]
Wang, Shu-Qing [1 ]
机构
[1] Tianjin Med Univ, Sch Pharm, Tianjin Key Lab Technol Enabling Dev Clin Therape, Tianjin 300070, Peoples R China
基金
中国国家自然科学基金;
关键词
oestrogen receptor; agonist; antagonist; molecular dynamics simulation; BREAST-CANCER-CELLS; LINEAR CONSTRAINT SOLVER; PARTICLE MESH EWALD; MESSENGER-RNA; FORCE-FIELD; IN-VITRO; 4-HYDROXYTAMOXIFEN; BINDING; ALPHA; ANTIESTROGENS;
D O I
10.1080/08927022.2012.717281
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Oestrogen receptor (ER) is a ligand-activated transcription factor which plays an important role in many physiological processes. The aim of this study was to explore the difference between agonist and antagonist recognition mode. Molecular dynamics simulation of ER/diethylstilbestrol and ER/4-hydroxytamoxifen complexes was carried out. Our research results indicate that Glu353 participates in both agonist and antagonist recognition; His524 is the key residue in agonist recognition; Met343, Leu346, Thr347 and Asp351 are the key residues in the antagonist recognition.
引用
收藏
页码:228 / 233
页数:6
相关论文
共 50 条
  • [21] CHARACTERIZATION OF POLYAMINES HAVING AGONIST, ANTAGONIST, AND INVERSE AGONIST EFFECTS AT THE POLYAMINE RECOGNITION SITE OF THE NMDA RECEPTOR
    WILLIAMS, K
    DAWSON, VL
    ROMANO, C
    DICHTER, MA
    MOLINOFF, PB
    NEURON, 1990, 5 (02) : 199 - 208
  • [22] Agonist and Antagonist Recognition by RIG-I, a Cytoplasmic Innate Immunity Receptor
    Ranjith-Kumar, C. T.
    Murali, Ayaluru
    Dong, Wen
    Srisathiyanarayanan, Dharmaiah
    Vaughan, Robert
    Ortiz-Alacantara, Joanna
    Bhardwaj, Kanchan
    Li, Xiaojun
    Li, Pingwei
    Kao, Cheng C.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (02) : 1155 - 1165
  • [23] Recognition of LXXLL by ligand binding domain of the Farnesoid X receptor in molecular dynamics simulation
    Zhang, Tao
    Dong, Xi-Cheng
    Chen, Min-Bo
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2006, 46 (06) : 2623 - 2630
  • [25] Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action
    C K Osborne
    A Wakeling
    R I Nicholson
    British Journal of Cancer, 2004, 90 : S2 - S6
  • [26] Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action
    Osborne, CK
    Wakeling, A
    Nicholson, RI
    BRITISH JOURNAL OF CANCER, 2004, 90 (Suppl 1) : S2 - S6
  • [27] Key differences in molecular complexes of the cholecystokinin receptor with structurally related peptide agonist, partial agonist, and antagonist
    Arlander, SJH
    Dong, MQ
    Ding, XQ
    Pinon, DI
    Miller, LJ
    MOLECULAR PHARMACOLOGY, 2004, 66 (03) : 545 - 552
  • [28] Molecular dynamics simulation studies for DNA sequence recognition by reactive metabolites of anticancer compounds
    Tumbi, Khaled M.
    Nandekar, Prajwal P.
    Shaikh, Naeem
    Kesharwani, Siddharth S.
    Sangamwar, Abhay T.
    JOURNAL OF MOLECULAR RECOGNITION, 2014, 27 (03) : 138 - 150
  • [29] Molecular Determinants of Agonist and Antagonist Signaling through the IL-36 Receptor
    Guenther, Sebastian
    Sundberg, Eric J.
    JOURNAL OF IMMUNOLOGY, 2014, 193 (02): : 921 - 930
  • [30] Molecular determinants of agonist and antagonist signaling through the IL-36 receptor
    Guenther, Sebastian
    Sundberg, Eric J.
    CYTOKINE, 2015, 76 (01) : 87 - 87